Form 8-K - Current report:
SEC Accession No. 0000950142-20-000265
Filing Date
2020-02-04
Accepted
2020-02-04 17:24:31
Documents
15
Period of Report
2020-02-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh2000243_8k.htm   iXBRL 8-K 33878
2 EXHIBIT 99.1 eh2000243_ex9901.htm EX-99.1 8597
7 GRAPHIC logo.jpg GRAPHIC 15757
  Complete submission text file 0000950142-20-000265.txt   290165

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE elan-20200204.xsd EX-101.SCH 3870
4 XBRL DEFINITION FILE elan-20200204_def.xml EX-101.DEF 28193
5 XBRL LABEL FILE elan-20200204_lab.xml EX-101.LAB 37024
6 XBRL PRESENTATION FILE elan-20200204_pre.xml EX-101.PRE 26818
12 EXTRACTED XBRL INSTANCE DOCUMENT eh2000243_8k_htm.xml XML 5199
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 20574984
SIC: 2834 Pharmaceutical Preparations